Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Endocrine‚ Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune‚ Endocrine & Metabolic Disorders)

Volume 7 Issue 3
ISSN: 1871-5303
eISSN: 2212-3873

 

   All Titles

  Implications of the Obesity Epidemic for Statin Therapy: Shifting Cholesterol Metabolism to a High Synthesis and Low Dietary Absorption State
  pp.153-166 (14) Authors: Michel R. Hoenig, Karam M. Kostner, Stephen J. Read, Philip J. Walker, John J. Atherton
 
 
      Abstract

Obesity and the metabolic syndrome are becoming one of the biggest health challenges of the 21st century. Cholesterol metabolism is significantly altered in both obesity and metabolic syndrome in that cholesterol synthesis is increased and absorption reduced and this has important implications for the treatment of lipid disorders in both obesity and the metabolic syndrome. In the present review we discuss these changes in detail especially in the context of a more standardized approach for cholesterol reduction like the TARGET LDL trial. Customized care is topical in lipidology as we strive to achieve LDL cholesterol and non-HDL cholesterol targets in every patient.

 
  Keywords: Cholesterol, cholestanol, statins, obesity, metabolic syndrome, diabetes, ezetimibe
  Affiliation: Department of Cardiology,Royal Brisbane&Women's Hospital, Herston, QLD 4029, Brisbane, Australia.
 
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers
www.benthamscience.com

 

  Copyright © 1994 - 2014   Bentham Science Publishers